Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00271206 · ClinicalTrials.gov registry record · Phase 1
Effect of Progesterone on Smoking Behavior in Male and Female Smokers
A Phase 1 study, sponsored by Yale University.
- Completed
- Registry status
- Phase 1
- Development phase
- 65
- Enrollment target
NCT00271206 is a Phase 1 study that has completed, run by Yale University. The registered enrollment target is 65 participants.
The verdict
NCT00271206, a Phase 1 study, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 65 participants
- Enrollment target
Study Summary
Past research on nicotine addiction has shown that changes in estradiol and progesterone hormone levels during menstruation may cause women to respond differently than men to nicotine. The purpose of this study is to examine the effects of progesterone on smoking behavior, nicotine withdrawal symptoms, and the reinforcing effects of smoking in men and women addicted to nicotine.
Interventions
- DRUG Progesterone
- DRUG sugar pill
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 65 participants |
| Start Date | 2004-09 |
| Est. Completion | 2008-09 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00271206
The ClinicalTrials.gov registry entry for NCT00271206 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 65 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Progesterone is the first listed.
NCT00271206 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00271206 about?
NCT00271206 is a clinical study titled "Effect of Progesterone on Smoking Behavior in Male and Female Smokers". Past research on nicotine addiction has shown that changes in estradiol and progesterone hormone levels during menstruation may cause women to respond differently than men to nicotine. The purpose of this study is to examine the effects of progesterone on smoking behavior, nicotine withdrawal sympto...
What is the current status of trial NCT00271206?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 65 participants. The study started on 2004-09. Estimated completion is 2008-09.
What interventions are being tested in trial NCT00271206?
The interventions under investigation include: Progesterone (DRUG), sugar pill (DRUG).
Who is sponsoring clinical trial NCT00271206?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.